Oral formulations and lipophilic salts of methylnaltrexone
US10507206B2 · kind B2 · utility
1Cited by
23References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2019 |
| Grant date | Dec 17, 2019 |
| Priority date | — |
| Expiry date | Jun 24, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D489/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.